<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>ABSTRACT: The implantable cardioverter defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) is the treatment of choice for life-threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Usually, the device is placed, by a subclavian access, on the upper portion of the pectoralis major muscle </plain></SENT>
<SENT sid="2" pm="."><plain>As a result, the visibility of the device and the wide subclavian scar create an important aesthetic deformity, especially in young women, evolving in a relevant psychosocial distress </plain></SENT>
<SENT sid="3" pm="."><plain>The authors report their experience with subpectoral <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation </plain></SENT>
<SENT sid="4" pm="."><plain>Between January 2001 and December 2011, approximately30 consecutive female patients underwent submuscular <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation or substitution, performed in collaboration with the cardiology team </plain></SENT>
<SENT sid="5" pm="."><plain>No significant complications, except 1 case of wound dehiscence and 2 cases of caudal dislocation of the device, were observed </plain></SENT>
<SENT sid="6" pm="."><plain>At 6 and 12 months' follow-up, no significant difference between preoperative and postoperative breast symmetry and volume was noticed </plain></SENT>
<SENT sid="7" pm="."><plain>The combined approach aims at reducing the visible signs of the procedure and improving the psychological outcomes </plain></SENT>
</text></document>